Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.
Guardado en:
| Autores principales: | Reiter, Russel J., Cardinali, Daniel Pedro, Neel, Richard L., Domínguez Rodriguez, Alberto, Brown, Gregory M., Tesarik, Jan |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
ST-Bio-Life LLC
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/13671 |
| Aporte de: |
Ejemplares similares
-
Molecular surveillance of SARS-CoV-2 in the province of Córdoba: monitoring of variants
por: Castro , G, et al.
Publicado: (2021) -
Low melatonin as a contributor to SARS-CoV-2 disease
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2022) -
An urgent proposal for the immediate use of melatonin as an adjuvant to anti- SARS-CoV-2 vaccination
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022) -
Wastewater based epidemiology: population circulation dynamics of SARS-CoV-2 and its variants of concern (VOC) in Córdoba city and Punilla‘s Valley.
por: Marinzalda, MA, et al.
Publicado: (2021) -
Infecciones persistentes por SARS-CoV-2 en inmunosuprimidos: reporte de casos en Córdoba
por: Pisano, MB, et al.
Publicado: (2022)